ADU-S100 Combines with Checkpoint Inhibition to Anti-Tumor CD8 + T Cell Response to Control Non-Injected Tumors.

Remaining Time -0:00
Progress: NaN%
Playback Rate
1.00x
information icon125927751
video icon10.47s